NCT01942343View on ClinicalTrials.gov

Akathisia in Post Operative Outpatients Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Akathisia
Interventions
DRUG

Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration

Trial Locations (1)

67000

Les Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT01942343 - Akathisia in Post Operative Outpatients Surgery | Biotech Hunter | Biotech Hunter